Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
KQB198 + Imatinib in 1st Line Advanced/Metastatic GIST
NCT07406633Phase 2Recruiting
- Sponsor
- Kumquat Biosciences
- Start
- Jun 2026
- Primary completion
- Oct 2027
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of KQB198 in gastrointestinal stromal tumor (GIST), sponsored by Kumquat Biosciences. Started Jun 2026; status: recruiting.
02
Drugs
KQB198
03
Conditions
gastrointestinal stromal tumor (GIST)
Beyond the preview
Go deeper on NCT07406633.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07406633.